The goal of our study was to assess the predictive value of radiomics features assessed on pre-treatment multi-phasic gadoxetic acid-enhanced (EOB-)MRI for prediction of response of hepatocellular carcinoma to 90Yttrium radioembolization (RE). We found that radiomics features measured at baseline were predictive of response assessed at 6 weeks and 6-12 months after treatment. These results indicate value of radiomics for prediction of RE response, which needs to be validated in a larger study.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords